From cancer to COVID-19, ImmunoScape’s Deep Immunomics platform sheds new light on individual responses to treatments and vaccines, creating breakthroughs in the fight against disease.
https://www.asianscientist.com/2021/08/features/immunoscape-deep-immunomics-platform-immunology/
Researchers were surprised to find memory T-cells in people with no history of SARS, COVID-19, or contact with SARS or COVID-19 patients.
https://www.asianscientist.com/2020/07/health/memory-t-cell-immunity-covid-19-patients-sars-cov-2/
This multi-institutional effort draws upon deep capabilities in skin research and cancer biology from Singapore and South Korea.
https://www.asianscientist.com/2018/07/academia/astar-korea-cc-skin-disorder-cancer-drugs/
Three Singapore-based teams working on myopia, cancer and liver disease will receive funding over the next three years.
https://www.asianscientist.com/2018/03/pharma/world-disease-research-grants/
Therapeutic antibodies offer promising new options for treating infectious diseases, including dengue, writes immunologist Dr Katja Fink.
https://www.asianscientist.com/2017/06/features/anti-dengue-antibodies/
Fetuses have immune cells that can launch an effective attack against infectious agents and yet do not react against maternal cells.
https://www.asianscientist.com/2017/06/in-the-lab/fetal-dendritic-cells/
Tessa Therapeutics has fully acquired Euchloe Bio, a biotech company focused on developing and commercializing therapeutic antibodies.
https://www.asianscientist.com/2017/03/pharma/tessa-therapeutics-euchloe-bio-singapore/
Researchers from Singapore have shown that an existing immune suppressing drug can be used to treat debilitating joint pain caused by the mosquito-borne virus.
https://www.asianscientist.com/2017/02/in-the-lab/chikugunya-fingolimod-joint/
When faced with a lack of certain ‘essential’ genes, yeast cells can cope by simply doubling up their chromosomes.
A single-cell RNA sequencing study has shown that dendritic cells are already committed to their downstream lineages in the bone marrow.
https://www.asianscientist.com/2015/07/in-the-lab/dc-lineage-commitment-sign-astar/
Infectious diseases such as dengue and influenza continue to plague the world despite our best efforts to develop vaccines and drugs. Sim Shuzhen takes stock of how scientists are faring in the f...
https://www.asianscientist.com/2015/04/features/trying-viral/
Collaborations with the Singapore Immunology Network and the Institute of Molecular and Cell Biology have helped Curiox validate their DropArray technology.
https://www.asianscientist.com/2015/04/academia/curiox-astar-develop-cheaper-multiplexing-assays/
Scientists have found that the drug metformin can indirectly boost existing TB therapy while avoiding drug resistance.
https://www.asianscientist.com/2014/12/in-the-lab/diabetes-drug-takes-target/
Lipids, rather than proteins, expressed by leukemia cells are a promising new target for T cell-driven cancer immunotherapy.
https://www.asianscientist.com/2014/06/in-the-lab/lipids-target-cancer-immunotherapy-2014/
A collaborative effort in Singapore will start a Phase IV clinical trial to understand age-related loss of immunity in the elderly.
https://www.asianscientist.com/2014/02/health/spore-study-loss-immunity-elderly-2014/
Researchers have identified house dust mites as the main cause of respiratory allergies in Singapore.
https://www.asianscientist.com/2014/02/health/dust-mites-main-allergies-singapore-2014/
A new study shows how golden staph identifies key immune cells and 'nukes' our body's immune response when it enters our skin.
https://www.asianscientist.com/2013/12/in-the-lab/golden-staph-paralyses-immune-defenses-2013/
Scientists have discovered the exact mode of action by plerixafor, a drug commonly prescribed to stimulate immune responses in patients suffering from neutropenia.
https://www.asianscientist.com/2013/11/pharma/mode-action-plerixafor-unraveled-2013/
Scientists have come up with a new strategy that cripples the ability of the dengue virus to escape the host immune system.
Scientists have discovered a new class of white blood cells that play a key role in defense against harmful fungal and bacterial infections.
https://www.asianscientist.com/2013/07/in-the-lab/class-white-blood-cells-discovered-2013/
Singapore's A*STAR and Switzerland's Cytos Biotechnology AG today announced the initiation of Phase I trials for their H1N1 influenza vaccine candidate.
Veredus has launched a lab-on-a-chip that can identify 13 different major tropical diseases from a single blood sample.
Researchers in Newcastle and Singapore have identified a new type of white blood cell that activates a killing immune response to an external source.
https://www.asianscientist.com/2012/08/in-the-lab/cd141hi-cross-presenting-dendritic-cells-2012/
An outstanding woman scientist from Singapore was announced this week as the recipient of the prestigious 2012 L’Oréal-UNESCO International Fellowship award.
A*STAR’s Singapore Immunology Network has inked a research collaboration agreement with French pharma company Servier.